ACCP Transplant PRN

  • Home
  • ACCP Transplant PRN

ACCP Transplant PRN American College of Clinical Pharmacy (ACCP) Transplant (TXP) Practice and Research Network (PRN)

The Immunology/Transplantation PRN promotes quality research, clinical practice, innovation, and education in the areas of immunology, and solid organ transplantation. The PRN represents a diverse group of professionals who share the common goal of improving patient outcomes as a result of the efforts in their field. The PRN is dedicated to achieving this goal by promoting information exchange in a cooperative, supportive atmosphere.

🚨BREAKING NEWS🚨It's   time!! This week, APPE student Christina Curreri is highlighting the importance of CMV prophylaxis...
12/08/2025

🚨BREAKING NEWS🚨

It's time!! This week, APPE student Christina Curreri is highlighting the importance of CMV prophylaxis treatment! CMV is a common opportunistic infection that transplant patients may be exposed to, and she covers the main medications utilized to treat this infection. 🦠🧫💊

🔔  👉🏻 swipe to learn more about the Transplant Pharmacy Group (TPG) at University Health!
08/08/2025

🔔

👉🏻 swipe to learn more about the Transplant Pharmacy Group (TPG) at University Health!

Happy Tuesday everyone!! We are excited to highlight an APPE student from Philadelphia College of Pharmacy (P*P)!! Chris...
05/08/2025

Happy Tuesday everyone!! We are excited to highlight an APPE student from Philadelphia College of Pharmacy (P*P)!!

Christina Curreri has recently completed a heart and lung transplant rotation at the Hospital of the University of Pennsylvania. Due to her personal connection to transplant and her rotational experiences, her passion for the field burned brighter than ever and even solidified her decision to pursue a career in the specialty. 🥳🔥

Stay tuned as she will be sharing clinical pearls and so much more surrounding her impactful transplant rotation. 🏥🚑

For the month of July, we’re highlighting some landmark studies that impacted the field of transplant.Today, we are high...
28/07/2025

For the month of July, we’re highlighting some landmark studies that impacted the field of transplant.

Today, we are highlighting the SCHEDULE trial, which demonstrates the role of everolimus and early CNI withdrawal in heart transplant recipients and the effects on renal function and cardiac allograft vasculopathy.

https://doi.org/10.1111/ajt.12809

Its   time! 🚨 This week Cassie Streblow, PharmD takes us on a dive into the use of buprenorphine, a unique medication th...
24/07/2025

Its time! 🚨 This week Cassie Streblow, PharmD takes us on a dive into the use of buprenorphine, a unique medication that plays a major role in managing opioid use disorder and chronic pain, perioperatively. 💊🔥

Swipe to learn about the differences between formulations and ASAM's latest guidance, and be sure to thank Cassie for a fantastic start to the 2025-26 academic year!

Does your center have a protocol for managing pain in these patients?

AST TxPharm COP & ACCP TXP PRN Present:When: Tuesday August 19, 20254PM EST / 3PM CST / 2PM MST /1PM PST Who: Presenters...
22/07/2025

AST TxPharm COP & ACCP TXP PRN Present:
When:
Tuesday August 19, 2025
4PM EST / 3PM CST / 2PM MST /1PM PST
Who:
Presenters:
Dr. Lyndsey Bowman Anger (Tampa General Hospital)
Dr. Idris Yakubu (VCU Health System)
Dr. Dawn Pluckrose (Tufts Medical Center)
Dr. Kayla Joyal (Massachusetts General Hospital)
Dr. Barrett Crowther (University of Colorado Hospital)
Dr. Emily Sartain (University of Colorado Hospital)

What:
Mentorship Tips and Tricks

Registration link:
https://accp.zoom.us/meeting/register/mrZoJyF1QkmL3Uk0frUYIQ
(will need to create a Zoom account if new to Zoom)

New podcast alert!💊🎙Check out Part 2 of the CMV in Cardiothoracic Transplant series from The mTOR You Know podcast!Drs. ...
21/07/2025

New podcast alert!💊🎙

Check out Part 2 of the CMV in Cardiothoracic Transplant series from The mTOR You Know podcast!

Drs. Margaret Jorgenson, Jillian Fose, and Hanna Kleiboeker from the University of Wisconsin return to share real-world cases, resistance management, and practical tips for building and refining a CMV stewardship program. A must-listen for anyone involved in transplant or infectious diseases care!

🎧 Listen here: https://creators.spotify.com/pod/profile/the-mtor-you-know/episodes/The-CMV-Playbook---Part-2-e35cqk5 (link also in bio)
🔔 Subscribe to The mTOR You Know for more expert transplant content!

Just like that, we are halfway through July! We are back with another  . This week Cassie Streblow, PharmD takes us on a...
17/07/2025

Just like that, we are halfway through July! We are back with another . This week Cassie Streblow, PharmD takes us on a deep dive into a rare but important neurologic complication: Calcineurin Inhibitor–Induced RCVS 🧠💥
Swipe through to check out serious complications, potential triggers, and what to do when transplant meds cause unexpected headaches (literally).

Have you ever cared for a RCVS patient??

For the month of July, we’re highlighting some older studies that impacted the field of transplant. Second up is this tr...
15/07/2025

For the month of July, we’re highlighting some older studies that impacted the field of transplant.

Second up is this trial which assessed the use of Alemtuzumab versus Basiliximab for induction in lung transplant recipients.


https://pubmed.ncbi.nlm.nih.gov/35720296/

Uh oh 😦
10/07/2025

Uh oh 😦

Does DGF after kidney transplant impact long-term cardiovascular outcomes? 🫀 The answer might surprise you! In today's  ...
08/07/2025

Does DGF after kidney transplant impact long-term cardiovascular outcomes? 🫀 The answer might surprise you! In today's , Cassie Streblow, PharmD highlights a recent article from AJT by Beaudry et al. looking at the incidence of MACE in kidney transplant recipients. 🫘 Let us know what your thoughts are below!

Manuscript Monday throwback edition!For the month of July we're highlighting some older studies that impacted the field ...
07/07/2025

Manuscript Monday throwback edition!

For the month of July we're highlighting some older studies that impacted the field of transplant.
First up is the DONATE-HCV trial which assessed outcomes of heart and lung transplants from HCV NAT+ donors to uninfected recipients.



https://doi.org/10.1056/nejmoa1812406

Address


Alerts

Be the first to know and let us send you an email when ACCP Transplant PRN posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

  • Want your practice to be the top-listed Clinic?

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram